
GC13014
AZD 5153
Also known as (3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one
orally available, bivalent inhibitor of the bromodomain and extraterminal (BET) protein BRD4
ChemicalCAS1869912-39-9MW479.6FormulaC25H33N7O3
- CAS number
- 1869912-39-9
- Molecular weight
- 479.6
- Formula
- C25H33N7O3
- Solubility
- ≤20mg/ml in ethanol;20mg/ml in DMSO;20mg/ml in dimethyl formamide
- InChIKey
- RSMYFSPOTCDHHJ-GOSISDBHSA-N
- Catalogue number
- GC13014
- Brand
- GLPBIO
Computed properties PubChem CID 118693659 · XLogP 2.4 · TPSA 88.3 Ų · H-bond donors 0
- XLogP
- 2.4
- TPSA
- 88.3 Ų
- H-bond donors
- 0
- H-bond acceptors
- 8
- Rotatable bonds
- 7
- Heavy atoms
- 35
SMILES C[C@@H]1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C
Computed descriptors from PubChem (CID 118693659), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il